Pulmonx Corporation LUNG
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.15% | -3.43% | 1.23% | 8.01% | 15.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.15% | -3.43% | 1.23% | 8.01% | 15.59% |
| Cost of Revenue | -18.09% | -17.73% | -6.48% | 7.21% | 19.45% |
| Gross Profit | 2.29% | 1.84% | 4.01% | 8.29% | 14.24% |
| SG&A Expenses | -15.84% | -10.39% | -4.44% | -0.81% | 5.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.88% | -9.30% | -2.01% | 3.14% | 9.61% |
| Operating Income | 31.08% | 18.63% | 7.07% | 4.15% | -1.22% |
| Income Before Tax | 25.48% | 15.74% | 7.19% | 4.50% | 0.22% |
| Income Tax Expenses | 29.50% | 9.96% | 42.54% | 25.20% | -32.68% |
| Earnings from Continuing Operations | 25.02% | 15.50% | 6.80% | 4.24% | 0.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.02% | 15.50% | 6.80% | 4.24% | 0.62% |
| EBIT | 31.08% | 18.63% | 7.07% | 4.15% | -1.22% |
| EBITDA | 31.35% | 18.46% | 6.43% | 3.64% | -1.56% |
| EPS Basic | 28.44% | 19.16% | 10.65% | 7.82% | 4.13% |
| Normalized Basic EPS | 28.87% | 19.38% | 8.20% | 5.14% | 0.73% |
| EPS Diluted | 28.44% | 19.16% | 10.65% | 7.82% | 4.13% |
| Normalized Diluted EPS | 28.87% | 19.38% | 8.20% | 5.14% | 0.73% |
| Average Basic Shares Outstanding | 5.00% | 4.69% | 4.38% | 4.02% | 3.65% |
| Average Diluted Shares Outstanding | 5.00% | 4.69% | 4.38% | 4.02% | 3.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |